SCHEMBL5732238

SCHEMBL5732238

CC(C)N=C=NC(C)C.O=C1CCC(=O)N1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28813360 0.75 ALDH1A1 (0.32)
Methyl Alcohol SCHEMBL28183931 0.74 BRD4 (0.33)
SCHEMBL1123 0.74
SCHEMBL338264 0.74 KDM4E (0.34)
SCHEMBL785147 0.74
SCHEMBL25175816 0.71
SCHEMBL21409686 0.71
Ammonia Solution, Strong SCHEMBL1914672 0.71
SCHEMBL21409789 0.71
SCHEMBL21409683 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1092726-B1 Radioactively-labeled somatostatin derived peptides for imaging and therapeutics uses DIATIDE INC (US) 2006-08-23 EP disclosed
EP-1572639-A4 INTEGRIN TARGETED IMAGING AGENTS BARNES JEWISH HOSPITAL (US) 2006-08-09 EP disclosed
EP-1572639-A1 INTEGRIN TARGETED IMAGING AGENTS Barnes Jewish Hospital (US) 2005-09-14 EP disclosed
WO-2003062198-A1 INTEGRIN TARGETED IMAGING AGENTS BARNES JEWISH HOSPITAL (US) 2003-07-31 WO disclosed